The major ghrelin forms, acylated ghrelin and des-acylated ghrelin, are novel gastrointestinal hormones. Moreover, emerging evidence indicates that these peptides may have other functions including neuro- and vaso-protection. Here, we investigated whether post-stroke treatment with acylated ghrelin or des-acylated ghrelin could improve functional and histological endpoints of stroke outcome in mice after transient middle cerebral artery occlusion (tMCAo). We found that des-acylated ghrelin (1 mg/kg) improved neurological and functional performance, reduced infarct and swelling, and decreased apoptosis. In addition, it reduced blood-brain barrier (BBB) disruption in vivo and attenuated the hyper-permeability of mouse cerebral microvascular endothelial cells after oxygen glucose deprivation and reoxygenation (OGD + RO). By contrast, acylated ghrelin (1 mg/kg or 5 mg/kg) had no significant effect on these endpoints of stroke outcome. Next we found that des-acylated ghrelin's vasoprotective actions were associated with increased expression of tight junction proteins (occludin and claudin-5), and decreased cell death. Moreover, it attenuated superoxide production, Nox activity and expression of 3-nitrotyrosine. Collectively, these results demonstrate that post-stroke treatment with des-acylated ghrelin, but not acylated ghrelin, protects against ischaemia/reperfusion-induced brain injury and swelling, and BBB disruption, by reducing oxidative and/or nitrosative damage.
Skip Nav Destination
Article navigation
September 2016
-
Cover Image
Cover Image
Corin protein expression in human renal proximal convoluted tubules as shown by brown staining in immunohistochemistry. See pp. 1655-1664 for further details. Image kindly provided by Qingyu Wu.
Research Article|
July 26 2016
Protective actions of des-acylated ghrelin on brain injury and blood–brain barrier disruption after stroke in mice Available to Purchase
Jacqueline M. Ku;
Jacqueline M. Ku
*Cerebrovascular and Stroke Laboratory, School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria 3083, Australia
Search for other works by this author on:
Mohammadali Taher;
Mohammadali Taher
*Cerebrovascular and Stroke Laboratory, School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria 3083, Australia
Search for other works by this author on:
Kai Yee Chin;
Kai Yee Chin
*Cerebrovascular and Stroke Laboratory, School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria 3083, Australia
Search for other works by this author on:
Tom Barsby;
Tom Barsby
*Cerebrovascular and Stroke Laboratory, School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria 3083, Australia
Search for other works by this author on:
Victoria Austin;
Victoria Austin
*Cerebrovascular and Stroke Laboratory, School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria 3083, Australia
Search for other works by this author on:
Connie H.Y. Wong;
Connie H.Y. Wong
†Centre for Inflammatory Diseases, Department of Medicine, Monash Medical Centre, Monash University, Melbourne, Victoria 3168, Australia
Search for other works by this author on:
Zane B. Andrews;
Zane B. Andrews
‡Department of Physiology, Monash University, Melbourne, Victoria 3800, Australia
Search for other works by this author on:
Sarah J. Spencer;
Sarah J. Spencer
*Cerebrovascular and Stroke Laboratory, School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria 3083, Australia
Search for other works by this author on:
Alyson A. Miller
*Cerebrovascular and Stroke Laboratory, School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria 3083, Australia
Correspondence: Dr Alyson A. Miller (email [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
February 02 2016
Revision Received:
May 26 2016
Accepted:
June 13 2016
Accepted Manuscript online:
June 14 2016
Online ISSN: 1470-8736
Print ISSN: 0143-5221
© 2016 The Author(s). published by Portland Press Limited on behalf of the Biochemical Society
2016
Clin Sci (Lond) (2016) 130 (17): 1545–1558.
Article history
Received:
February 02 2016
Revision Received:
May 26 2016
Accepted:
June 13 2016
Accepted Manuscript online:
June 14 2016
Citation
Jacqueline M. Ku, Mohammadali Taher, Kai Yee Chin, Tom Barsby, Victoria Austin, Connie H.Y. Wong, Zane B. Andrews, Sarah J. Spencer, Alyson A. Miller; Protective actions of des-acylated ghrelin on brain injury and blood–brain barrier disruption after stroke in mice. Clin Sci (Lond) 1 September 2016; 130 (17): 1545–1558. doi: https://doi.org/10.1042/CS20160077
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |